BIOMAT Database Logo BIOMAT Database Logo

[Carbohydrate antigen (CA-19-9) in the blood serum of patients with benign and malignant liver diseases]. 1985

A S Ametov, and Iu N Kasatkin, and V V Mit'kov, and I V Gur'eva

The concentration of a new tumor marker CA-19-9 was determined in the blood serum of 51 patients with different diseases and in 38 healthy persons. In 95% of the examined persons, the concentration of CA-19-9 in the blood serum did not exceed 15 Units/ml in health. In the patients with benign focal and diffuse liver diseases and in the patients with rectal cancer without metastases to the liver, the level and frequency of the elevated CA-19-9 content in the blood serum did not practically differ from those in health. In primary and metastatic liver cancer, the CA-19-9 content was considerably elevated in all the patients. The combination of the CA-19-9 and CEA tests did not add to the efficacy of differential diagnosis between benign and malignant liver lesions.

UI MeSH Term Description Entries
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D002272 Carcinoembryonic Antigen A glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment. Antigens, CD66e,CD66e Antigen,Antigen, CD66e,Antigen, Carcinoembryonic,CD66e Antigens
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor
D015295 Antigens, Tumor-Associated, Carbohydrate Carbohydrate antigens expressed by malignant tissue. They are useful as tumor markers and are measured in the serum by means of a radioimmunoassay employing monoclonal antibodies. Antigens, Carbohydrate, Tumor-Associated,CA Antigens,Cancer-Associated Carbohydrate Antigens,Carbohydrate Antigens, Tumor-Associated,Tumor-Associated Carbohydrate Antigens,Antigen, Carcinoma-Associated,CA Antigen,CA(Oxford) Antigen,Carcinoma-Associated Antigen,Epitectin,Antigen, CA,Antigen, Carcinoma Associated,Antigens, CA,Antigens, Cancer-Associated Carbohydrate,Antigens, Tumor-Associated Carbohydrate,Cancer Associated Carbohydrate Antigens,Carbohydrate Antigens, Cancer-Associated,Carbohydrate Antigens, Tumor Associated,Carcinoma Associated Antigen,Tumor Associated Carbohydrate Antigens

Related Publications

A S Ametov, and Iu N Kasatkin, and V V Mit'kov, and I V Gur'eva
[Carbohydrate antigen 19-9 (CA 19-9) in pleural effusions of malignant and benign origin].
January 1988, Plucne bolesti : casopis Udruzenja pneumoftiziologa Jugoslavije = the journal of Yugoslav Association of Phthisiology and Pneumology,
A S Ametov, and Iu N Kasatkin, and V V Mit'kov, and I V Gur'eva
The correlation of serum carbohydrate antigen 19-9 with benign hydronephrosis.
January 2002, The Journal of urology,
A S Ametov, and Iu N Kasatkin, and V V Mit'kov, and I V Gur'eva
Elevated carbohydrate antigen 19-9 (CA 19-9) in patients with Echinococcus infection.
June 2001, Clinical chemistry and laboratory medicine,
A S Ametov, and Iu N Kasatkin, and V V Mit'kov, and I V Gur'eva
[Carbohydrate antigens CA 19-9, CA 242, CA 50 in liver diseases].
January 1998, Wiadomosci lekarskie (Warsaw, Poland : 1960),
A S Ametov, and Iu N Kasatkin, and V V Mit'kov, and I V Gur'eva
[The concentration of carcinoembryonic antigen and carbohydrate antigen Ca-19-9 in the blood serum in cancerous diseases of the gastrointestinal tract].
November 1989, Meditsinskaia radiologiia,
A S Ametov, and Iu N Kasatkin, and V V Mit'kov, and I V Gur'eva
[CA 19-9 in patients with benign pulmonary diseases].
October 1990, Nihon Kyobu Shikkan Gakkai zasshi,
A S Ametov, and Iu N Kasatkin, and V V Mit'kov, and I V Gur'eva
[Studies on the serum levels of a carbohydrate antigen 19-9 (CA 19-9) in patients with ovarian cancer].
December 1984, Igaku kenkyu. Acta medica,
A S Ametov, and Iu N Kasatkin, and V V Mit'kov, and I V Gur'eva
Benign Hydronephrosis and Elevated of Serum Levels of Carbohydrate Antigen CA 19-9: A Case Report.
June 2016, The American journal of case reports,
A S Ametov, and Iu N Kasatkin, and V V Mit'kov, and I V Gur'eva
CA 19-9 and CA 50 in benign and malignant pancreatic and biliary diseases.
May 1988, Cancer,
A S Ametov, and Iu N Kasatkin, and V V Mit'kov, and I V Gur'eva
[Serum carcinoembryonic antigen (CEA) and carbohydrate antigen (CA 19-9) values in patients with pancreatic cancer or pancreatitis].
March 1991, Changgeng yi xue za zhi,
Copied contents to your clipboard!